WeChat Mini Program
Old Version Features

Correlative Biomarker Analyses for Optimal Therapeutic Dose Determination of ABBV-383, a B-cell Maturation Antigen (BCMA) X CD3 Bispecific Antibody, in Patients with Relapsed/refractory Multiple Myeloma (RRMM).

Aarif Ahsan,Christine Mantis, Xizhi (Adam) Luo, Catherine C. Zhang,Cesar Rodriguez Valdes,Peter M. Voorhees,Anita D'Souza,Alfred Chung,Sascha Tuchman,Hana Safah,John T. Mckay,Katja C. Weisel,Raphael Teipel,Neha Korde,Ravi Vij,Shaji Kumar, Orlando Felix Bueno,Rajvineeth Kumar Pothacamury,Chetasi Talati,Jeremy A. Ross

JOURNAL OF CLINICAL ONCOLOGY（2024）

Cited 0|Views8
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined